Thailand pushed back its rollout of AstraZeneca’s coronavirus vaccine Friday over concerns about people who received the shot developing blood clots.
The move came after more than half a dozen European nations stopped using some or all of their AstraZeneca doses while officials investigated the cases, which have not been definitively linked to the British drugmaker’s vaccine.
Thailand was supposed to start its AstraZeneca vaccination drive Friday by jabbing prime minister Prayut Chan-o-cha and his cabinet officials.
But Thai officials delayed the vaccine campaign to wait for the results of a safety investigation in Europe, where at least two people who took AstraZeneca’s vaccine developed fatal blood clots.
“AstraZeneca’s vaccine is of good quality and efficacy,” the Thai Ministry of Public Health said in a news release, according to a translation.